Osteoporosis drug registration cancelled in Saudi Arabia
23/07/2014 6:57 am EDT

share with your network:

The Saudi Food and Drug Authority (SFDA) has announced the cancellation of the registration of the medical product Protelos, which is used to treat osteoporosis, Saudi Gazette has reported. The decision was made based on the recommendation of the committee in charge of registering the medication of pharmaceutical plants, which said that the product’s risks outweigh its therapeutic benefits. The SFDA has called on users to stop taking the medicine, noting that the authorities will take it off market shelves.

About the Author

share with your network:

Share your view

© 1996-2016 Media quest FZ LLC A media and entertainment company
Middle East Main Office
[email protected]
© 2016 Dubai Business | Ameinfo . All rights Reserved.